Abstract:
The invention relates to a pharmaceutical presentation form for the oral administration of a poorly soluble active compound (D-24 851; INN: indibulin) in the form of an aqueous drink solution, and a method for its preparation.
Abstract:
The present invention relates to a pharmaceutical formulation for oral administration of the poorly soluble and therefore hardly bioavailable tubulin inhibitor Indibulin and a process for its manufacture. In particular, there is provided a pharmaceutical formulation of lndibulin for oral administration comprising a granulate containing micronized lndibulin having a particle size of less than 20 µm for at least 99 vol.-% of the particles, at least one hydrophilic surfactant, and one or more capsulation excipients.
Abstract:
La presente invencion se refiere a una formulacion farmaceutica para administracion oral de un inhibidor de tubulina, Indubulina, pobremente soluble y por lo tanto escasamente biodisponible y un procedimiento para su fabricacion. En particular, se proporciona una formulacion farmaceutica de Indibulina para administracion oral, que comprende un granulo que contiene Indibulina micronizada teniendo un tamano de particula de menos de 20 ??m para por lo menos 99%/volumen de las particulas, por lo menos un agente tensoactivo, y uno o mas excipientes de encapsulacion.